Gastrointestinal stromal tumor other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
Varun Kumar (talk | contribs)
Created page with "{{Gastrointestinal stromal tumor}} {{CMG}} ==Biopsy== A biopsy sample will be investigated under the microscope. The [[histopathology|histopathologis..."
 
Kalsang Dolma (talk | contribs)
No edit summary
Line 1: Line 1:
__NOTOC__
{{Gastrointestinal stromal tumor}}
{{Gastrointestinal stromal tumor}}
{{CMG}}
{{CMG}}
==Overview==


==Biopsy==
==Biopsy==
A [[biopsy]] sample will be investigated under the [[light microscopy|microscope]]. The [[histopathology|histopathologist]] identifies the characteristics of GISTs (spindle cells in 70-80%, epitheloid aspect in 20-30%). Smaller tumors can usually be found to the muscularis propria layer of the intestinal wall.  Large ones grow, mainly outward, from the bowel wall until the point where they outstrip their blood supply and necrose (die) on the inside, forming a cavity that may eventually come to communicate with the bowel lumen.
* A [[biopsy]] sample will be investigated under the [[light microscopy|microscope]]. The [[histopathology|histopathologist]] identifies the characteristics of GISTs (spindle cells in 70-80%, epitheloid aspect in 20-30%). Smaller tumors can usually be found to the muscularis propria layer of the intestinal wall.  Large ones grow, mainly outward, from the bowel wall until the point where they outstrip their blood supply and necrose (die) on the inside, forming a cavity that may eventually come to communicate with the bowel lumen.
 
* When GIST is suspected—as opposed to other causes for similar tumors—the histopathologist can use [[immunohistochemistry]] (specific [[antibody|antibodies]] that stain the molecule [[CD117]] (also known as ''c-kit'') —see below). 95% of all GISTs are CD117-positive (other possible markers include CD34, desmin, vimentin and others). Other cells that show CD117 positivity are [[mast cell]]s.


When GIST is suspected—as opposed to other causes for similar tumors—the histopathologist can use [[immunohistochemistry]] (specific [[antibody|antibodies]] that stain the molecule [[CD117]] (also known as ''c-kit'') —see below). 95% of all GISTs are CD117-positive (other possible markers include CD34, desmin, vimentin and others). Other cells that show CD117 positivity are [[mast cell]]s.
* Some tumors of the stomach and small bowel referred to as [[leiomyosarcoma]]s (malignant tumor of [[smooth muscle]]) would most likely be reclassified as GISTs today on the basis of immunohistochemical staining.


Some tumors of the stomach and small bowel referred to as [[leiomyosarcoma]]s (malignant tumor of [[smooth muscle]]) would most likely be reclassified as GISTs today on the basis of immunohistochemical staining.
==References==
==References==
{{reflist|2}}
{{reflist|2}}
Line 14: Line 18:
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Disease]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 18:58, 12 September 2012

Gastrointestinal stromal tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Gastrointestinal stromal tumor from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gastrointestinal stromal tumor other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gastrointestinal stromal tumor other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gastrointestinal stromal tumor other diagnostic studies

CDC on Gastrointestinal stromal tumor other diagnostic studies

Gastrointestinal stromal tumor other diagnostic studies in the news

Blogs on Gastrointestinal stromal tumor other diagnostic studies

Directions to Hospitals Treating Gastrointestinal stromal tumor

Risk calculators and risk factors for Gastrointestinal stromal tumor other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Biopsy

  • A biopsy sample will be investigated under the microscope. The histopathologist identifies the characteristics of GISTs (spindle cells in 70-80%, epitheloid aspect in 20-30%). Smaller tumors can usually be found to the muscularis propria layer of the intestinal wall. Large ones grow, mainly outward, from the bowel wall until the point where they outstrip their blood supply and necrose (die) on the inside, forming a cavity that may eventually come to communicate with the bowel lumen.
  • When GIST is suspected—as opposed to other causes for similar tumors—the histopathologist can use immunohistochemistry (specific antibodies that stain the molecule CD117 (also known as c-kit) —see below). 95% of all GISTs are CD117-positive (other possible markers include CD34, desmin, vimentin and others). Other cells that show CD117 positivity are mast cells.
  • Some tumors of the stomach and small bowel referred to as leiomyosarcomas (malignant tumor of smooth muscle) would most likely be reclassified as GISTs today on the basis of immunohistochemical staining.

References


Template:WikiDoc Sources